IDH1 and oligodendroglioma: Historically they were defined by histopathological features, but the 2021 WHO diagnostic criteria defined oligodendroglioma by molecular markers, specifically the co-occurrence of an IDH1 or IDH2 mutation and a 1p/19q codeletion [2].